Transaction in Own Shares

Summary by AI ^BETAClose X

QinetiQ Group plc announced on February 4, 2026, that it purchased 120,000 of its ordinary shares on February 3, 2026, as part of its ongoing share buyback program. The average price paid per share was 494.32 pence, with the highest price at 497.40 pence and the lowest at 491.40 pence. These shares will be cancelled, reducing the total number of ordinary shares in issue to 529,486,067, which will also serve as the denominator for shareholder notification calculations under the Disclosure and Transparency Rules.

Disclaimer*

QinetiQ Group plc

04 February 2026

QinetiQ Group plc

4 February 2026

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that on 3 February 2026 it has purchased, in accordance with the authority granted by shareholders at the annual general meeting of the Company held on
17 July 2025, the following number of its ordinary shares of 1 pence each (Shares) on the London Stock Exchange, pursuant to the latest tranche of its existing share buyback programme the commencement of which was announced on 17 November 2025.

The Company intends to cancel the purchased shares.

Description of Shares:	QinetiQ Group plc- ordinary shares of 1 pence each (ISIN: GB00B0WMWD03)
Date of transaction	3 February 2026
Number of Shares purchased:	120,000
Highest price paid per Share (pence):	497.40
Lowest price paid per Share (pence):	491.40
Average price paid per Share (pence):	494.3213
Broker:	Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis) ("Deutsche Numis")

Aggregate information:

Venue	Weighted average price paid per share (GBp)	Aggregate number of shares purchased	Lowest price paid per share (GBp)	Highest price paid per share (GBp)
London Stock Exchange	494.3552	70,000	491.40	497.40
Chi-X (CXE)	494.2581	20,000	492.00	497.40
BATS (BXE)	494.2843	30,000	492.00	497.20

This announcement is prepared on a trade basis. It is expected the shares purchased will be delivered to the Company within two working days. The total voting rights referred to below is prepared on a settlement basis.

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 529,486,067. The Company does not hold any ordinary shares in treasury. Therefore, the total voting rights in the Company will be 529,486,067. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/5833R_1-2026-2-3.pdf

This announcement will also be available on QinetiQ Group plc's website at: https://www.qinetiq.com/en/investors.

Enquiries to:

Andrew Carter, Group Director Investor Relations:	+44 (0) 7392 289116
Stephanie Mann, Group Head of Media Relations:	+44 (0) 7770 720268
James Field, Company Secretary:	+44 (0) 7841 662957

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END